Modern Approaches to the Management of Patients with Hyperkaliemia
Hyperkalemia is the most common electrolyte imbalance in clinical practice. Hyperkalemia can be caused by an increased intake of potassium into the body, the shift of potassium out of cells or an abnormal renal potassium excretion. This condition is associated with a high risk of death from arrhythm...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2022-02-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/1370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839572736341442560 |
|---|---|
| author | E. V. Reznik A. I. Selivanov A. R. Lutsenko L. A. Garanina G. N. Golukhov |
| author_facet | E. V. Reznik A. I. Selivanov A. R. Lutsenko L. A. Garanina G. N. Golukhov |
| author_sort | E. V. Reznik |
| collection | DOAJ |
| description | Hyperkalemia is the most common electrolyte imbalance in clinical practice. Hyperkalemia can be caused by an increased intake of potassium into the body, the shift of potassium out of cells or an abnormal renal potassium excretion. This condition is associated with a high risk of death from arrhythmias; therefore, even a slight deviation of the serum potassium level from the norm requires immediate correction. Modern approaches to the treatment of hyperkalemia include the elimination of predictors and the potassium-lowering drugs. Although inhibitors of the renin-angiotensin-aldosterone system are currently the best cardionephroprotective drugs, their administration can lead to hyperkalemia too, especially in heart failure, chronic kidney disease and diabetes mellitus. The article discusses in detail the physiology of potassium metabolism, possible predictors, prevention and treatment of hyperkalemia. |
| format | Article |
| id | doaj-art-852c8b51c2b64784acddd488ba2a3bf1 |
| institution | Matheson Library |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| publishDate | 2022-02-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj-art-852c8b51c2b64784acddd488ba2a3bf12025-08-04T14:09:48ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642022-02-0112152110.20514/2226-6704-2022-12-1-5-21874Modern Approaches to the Management of Patients with HyperkaliemiaE. V. Reznik0A. I. Selivanov1A. R. Lutsenko2L. A. Garanina3G. N. Golukhov4Russian National Research Medical University (RNRMU) n.a. N. I. Pirogov; City Clinical Hospital n.a. V. M. Buyanov of Healthcare Department of Moscow; City Clinical Hospital № 31 of Healthcare Department of MoscowRussian National Research Medical University (RNRMU) n.a. N. I. Pirogov; City Clinical Hospital n.a. V. M. Buyanov of Healthcare Department of MoscowRussian National Research Medical University (RNRMU) n.a. N. I. PirogovCity Clinical Hospital n.a. V. M. Buyanov of Healthcare Department of MoscowRussian National Research Medical University (RNRMU) n.a. N. I. Pirogov; City Clinical Hospital № 31 of Healthcare Department of MoscowHyperkalemia is the most common electrolyte imbalance in clinical practice. Hyperkalemia can be caused by an increased intake of potassium into the body, the shift of potassium out of cells or an abnormal renal potassium excretion. This condition is associated with a high risk of death from arrhythmias; therefore, even a slight deviation of the serum potassium level from the norm requires immediate correction. Modern approaches to the treatment of hyperkalemia include the elimination of predictors and the potassium-lowering drugs. Although inhibitors of the renin-angiotensin-aldosterone system are currently the best cardionephroprotective drugs, their administration can lead to hyperkalemia too, especially in heart failure, chronic kidney disease and diabetes mellitus. The article discusses in detail the physiology of potassium metabolism, possible predictors, prevention and treatment of hyperkalemia.https://www.medarhive.ru/jour/article/view/1370hyperkalemiapotassiumecgacute kidney injurychronic kidney diseaserenin–angiotensin–aldosterone system inhibitors |
| spellingShingle | E. V. Reznik A. I. Selivanov A. R. Lutsenko L. A. Garanina G. N. Golukhov Modern Approaches to the Management of Patients with Hyperkaliemia Архивъ внутренней медицины hyperkalemia potassium ecg acute kidney injury chronic kidney disease renin–angiotensin–aldosterone system inhibitors |
| title | Modern Approaches to the Management of Patients with Hyperkaliemia |
| title_full | Modern Approaches to the Management of Patients with Hyperkaliemia |
| title_fullStr | Modern Approaches to the Management of Patients with Hyperkaliemia |
| title_full_unstemmed | Modern Approaches to the Management of Patients with Hyperkaliemia |
| title_short | Modern Approaches to the Management of Patients with Hyperkaliemia |
| title_sort | modern approaches to the management of patients with hyperkaliemia |
| topic | hyperkalemia potassium ecg acute kidney injury chronic kidney disease renin–angiotensin–aldosterone system inhibitors |
| url | https://www.medarhive.ru/jour/article/view/1370 |
| work_keys_str_mv | AT evreznik modernapproachestothemanagementofpatientswithhyperkaliemia AT aiselivanov modernapproachestothemanagementofpatientswithhyperkaliemia AT arlutsenko modernapproachestothemanagementofpatientswithhyperkaliemia AT lagaranina modernapproachestothemanagementofpatientswithhyperkaliemia AT gngolukhov modernapproachestothemanagementofpatientswithhyperkaliemia |